DBVE-PC regimen
|
WikiDoc Resources for DBVE-PC regimen |
|
Articles |
|---|
|
Most recent articles on DBVE-PC regimen Most cited articles on DBVE-PC regimen |
|
Media |
|
Powerpoint slides on DBVE-PC regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on DBVE-PC regimen at Clinical Trials.gov Trial results on DBVE-PC regimen Clinical Trials on DBVE-PC regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on DBVE-PC regimen NICE Guidance on DBVE-PC regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on DBVE-PC regimen Discussion groups on DBVE-PC regimen Patient Handouts on DBVE-PC regimen Directions to Hospitals Treating DBVE-PC regimen Risk calculators and risk factors for DBVE-PC regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for DBVE-PC regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: ABVE-PC Regimen; Adriamycin-Bleomycin-Vincristine-Etoposide/Prednisone-Cyclophosphamide Regimen; DBVE-PC; POG 9245 Regimen
Overview
DBVE-PC regimen refers to a regimen consisting of doxorubicin, bleomycin, vincristine, etoposide, prednisone and cyclophosphamide, given in combination with radiation therapy and used for the treatment of high-risk, childhood Hodgkin's lymphoma.[1][2]
Regimen
DDoxorubicin
BBleomycin
VVincristine
EEtoposide
PPrednisone
CCyclophosphamide
Indications
- High-risk, childhood Hodgkin's lymphoma[3]
References
- ↑ "NCI Thesaurus".
- ↑ "R-CHOP - National Cancer Institute".
- ↑ Schwartz CL, Constine LS, Villaluna D, London WB, Hutchison RE, Sposto R; et al. (2009). "A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425". Blood. 114 (10): 2051–9. doi:10.1182/blood-2008-10-184143. PMC 2744567. PMID 19584400.